vs
艾仕得（AXTA）与费森尤斯医疗（FMS）财务数据对比。点击上方公司名可切换其他公司
费森尤斯医疗的季度营收约是艾仕得的4.3倍（$5.5B vs $1.3B），费森尤斯医疗净利率更高（7.9% vs 4.8%，领先3.2%），费森尤斯医疗同比增速更快（-0.3% vs -3.7%）
艾仕得是源自美国的专业涂料供应商，总部位于宾夕法尼亚州费城，注册地为百慕大。公司主营乘用车、商用车、工业场景及修补用途涂料的研发与生产，业务覆盖全球130个国家，拥有近1.3万名员工，服务超10万家客户。
费森尤斯医疗是德国知名医疗保健企业，核心业务为肾脏透析服务，在全球运营4171家门诊透析中心，服务约34.54万名患者。公司主要为终末期肾病患者提供治疗服务，该类患者需终身每周接受3次透析治疗以维持生命。
AXTA vs FMS — 直观对比
营收规模更大
FMS
是对方的4.3倍
$1.3B
营收增速更快
FMS
高出3.4%
-3.7%
净利率更高
FMS
高出3.2%
4.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $5.5B |
| 净利润 | $60.0M | $434.2M |
| 毛利率 | 33.4% | 27.4% |
| 营业利润率 | 12.8% | 11.7% |
| 净利率 | 4.8% | 7.9% |
| 营收同比 | -3.7% | -0.3% |
| 净利润同比 | -56.2% | 240.4% |
| 每股收益（稀释后） | $0.28 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXTAFMS
| Q4 25 | $1.3B | $5.5B | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | $5.5B | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.3B | — |
净利润AXTAFMS
| Q4 25 | $60.0M | $434.2M | ||
| Q3 25 | $110.0M | — | ||
| Q2 25 | $109.0M | — | ||
| Q1 25 | $99.0M | — | ||
| Q4 24 | $137.0M | $127.6M | ||
| Q3 24 | $101.0M | — | ||
| Q2 24 | $112.0M | — | ||
| Q1 24 | $41.0M | — |
毛利率AXTAFMS
| Q4 25 | 33.4% | 27.4% | ||
| Q3 25 | 34.9% | — | ||
| Q2 25 | 35.0% | — | ||
| Q1 25 | 34.3% | — | ||
| Q4 24 | 34.1% | 25.0% | ||
| Q3 24 | 35.0% | — | ||
| Q2 24 | 34.0% | — | ||
| Q1 24 | 33.2% | — |
营业利润率AXTAFMS
| Q4 25 | 12.8% | 11.7% | ||
| Q3 25 | 15.8% | — | ||
| Q2 25 | 14.8% | — | ||
| Q1 25 | 13.9% | — | ||
| Q4 24 | 14.3% | 5.1% | ||
| Q3 24 | 14.6% | — | ||
| Q2 24 | 15.2% | — | ||
| Q1 24 | 9.4% | — |
净利率AXTAFMS
| Q4 25 | 4.8% | 7.9% | ||
| Q3 25 | 8.5% | — | ||
| Q2 25 | 8.4% | — | ||
| Q1 25 | 7.8% | — | ||
| Q4 24 | 10.5% | 2.3% | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | 8.3% | — | ||
| Q1 24 | 3.2% | — |
每股收益（稀释后）AXTAFMS
| Q4 25 | $0.28 | — | ||
| Q3 25 | $0.51 | — | ||
| Q2 25 | $0.50 | — | ||
| Q1 25 | $0.45 | — | ||
| Q4 24 | $0.63 | — | ||
| Q3 24 | $0.46 | — | ||
| Q2 24 | $0.51 | — | ||
| Q1 24 | $0.18 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $657.0M | $1.7B |
| 总债务越低越好 | $3.2B | — |
| 股东权益账面价值 | $2.3B | $15.4B |
| 总资产 | $7.6B | $33.5B |
| 负债/权益比越低杠杆越低 | 1.36× | — |
8季度趋势，按日历期对齐
现金及短期投资AXTAFMS
| Q4 25 | $657.0M | $1.7B | ||
| Q3 25 | $606.0M | — | ||
| Q2 25 | $625.0M | — | ||
| Q1 25 | $575.0M | — | ||
| Q4 24 | $593.0M | $1.3B | ||
| Q3 24 | $567.0M | — | ||
| Q2 24 | $840.0M | — | ||
| Q1 24 | $624.0M | — |
总债务AXTAFMS
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.4B | — | ||
| Q1 25 | $3.4B | — | ||
| Q4 24 | $3.4B | — | ||
| Q3 24 | $3.5B | — | ||
| Q2 24 | $3.6B | — | ||
| Q1 24 | $3.4B | — |
股东权益AXTAFMS
| Q4 25 | $2.3B | $15.4B | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.1B | — | ||
| Q4 24 | $1.9B | $17.0B | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.7B | — |
总资产AXTAFMS
| Q4 25 | $7.6B | $33.5B | ||
| Q3 25 | $7.8B | — | ||
| Q2 25 | $7.8B | — | ||
| Q1 25 | $7.4B | — | ||
| Q4 24 | $7.2B | $36.3B | ||
| Q3 24 | $7.5B | — | ||
| Q2 24 | $7.3B | — | ||
| Q1 24 | $7.1B | — |
负债/权益比AXTAFMS
| Q4 25 | 1.36× | — | ||
| Q3 25 | 1.48× | — | ||
| Q2 25 | 1.50× | — | ||
| Q1 25 | 1.64× | — | ||
| Q4 24 | 1.78× | — | ||
| Q3 24 | 1.84× | — | ||
| Q2 24 | 2.02× | — | ||
| Q1 24 | 1.97× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $344.0M | $2.9B |
| 自由现金流经营现金流 - 资本支出 | $286.0M | — |
| 自由现金流率自由现金流/营收 | 22.7% | — |
| 资本支出强度资本支出/营收 | 4.6% | — |
| 现金转化率经营现金流/净利润 | 5.73× | 6.67× |
| 过去12个月自由现金流最近4个季度 | $453.0M | — |
8季度趋势，按日历期对齐
经营现金流AXTAFMS
| Q4 25 | $344.0M | $2.9B | ||
| Q3 25 | $137.0M | — | ||
| Q2 25 | $142.0M | — | ||
| Q1 25 | $26.0M | — | ||
| Q4 24 | $234.0M | $2.6B | ||
| Q3 24 | $194.0M | — | ||
| Q2 24 | $114.0M | — | ||
| Q1 24 | $34.0M | — |
自由现金流AXTAFMS
| Q4 25 | $286.0M | — | ||
| Q3 25 | $87.0M | — | ||
| Q2 25 | $97.0M | — | ||
| Q1 25 | $-17.0M | — | ||
| Q4 24 | $172.0M | — | ||
| Q3 24 | $161.0M | — | ||
| Q2 24 | $91.0M | — | ||
| Q1 24 | $12.0M | — |
自由现金流率AXTAFMS
| Q4 25 | 22.7% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 7.4% | — | ||
| Q1 25 | -1.3% | — | ||
| Q4 24 | 13.1% | — | ||
| Q3 24 | 12.2% | — | ||
| Q2 24 | 6.7% | — | ||
| Q1 24 | 0.9% | — |
资本支出强度AXTAFMS
| Q4 25 | 4.6% | — | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | 3.4% | — | ||
| Q1 25 | 3.4% | — | ||
| Q4 24 | 4.7% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 1.7% | — |
现金转化率AXTAFMS
| Q4 25 | 5.73× | 6.67× | ||
| Q3 25 | 1.25× | — | ||
| Q2 25 | 1.30× | — | ||
| Q1 25 | 0.26× | — | ||
| Q4 24 | 1.71× | 20.20× | ||
| Q3 24 | 1.92× | — | ||
| Q2 24 | 1.02× | — | ||
| Q1 24 | 0.83× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXTA
| Refinish | $509.0M | 40% |
| Light Vehicle | $372.0M | 29% |
| Industrial | $282.0M | 22% |
| Commercial Vehicle | $99.0M | 8% |
FMS
暂无分部数据
